Xconomy
"Alder, Bristol Arthritis Drug Shows "Outstanding" Results in Trial, Lead Researcher Says"
Monday, May 17, 2010

Xconomy
"Alder seeks to treat cancer in a radical way"
Thursday, May 13, 2010

Fierce Biotech
"The San Francisco treat"
Thursday, January 14, 2010

Xconomy
"Alder Rises From Ashes of Layoffs to Become Seattle Biotech Force"
Monday, January 4, 2010

BioCentury
"Life Beyond Orencia"
Monday, November 16, 2009

BioWorld Today
"Yeastward Ho! Alder’s Antibody Method Nets Jumbo BMS Deal"
Wednesday, November 11, 2009

Xconomy Seattle
"Alder and New Partner, Bristol, to Give Amgen and Abbott a Run for Their Money"
Wednesday, November 11, 2009

The Pink Sheet Daily
"Bristol Pays $85 Million Upfront to Acquire RA Compound from Alder"
Tuesday, November 10, 2009

Fierce Biotech
"Alder bags $1B RA licensing deal for lead drug"
Tuesday, November 10, 2009

Xconomy Seattle
"Alder Scores Deal With Bristol-Myers Potentially Worth $1 Billion"
Tuesday, November 10, 2009

NWJobs.com
"Winner: People's Choice, Favorite Biotech Company"
Wednesday, October 28, 2009

Xconomy Seattle
"Invest Northwest Notebook: Five of Seattle’s Next-Generation Life Sciences Innovators Seek to Adapt"
Thursday, March 19, 2009

Xconomy Seattle
"Alder Gets Early Christmas Present: FDA Slaps Down Its Rival, Roche"
Monday, December 8, 2008

Xconomy Seattle
"Alder Sets Stage for Showdown With Roche, With "Fast Follower" Antibody Drug Strategy"
Thursday, September 18, 2008

Seattle Times
"Bothell biotech firm Alder gets ready to grow in antibodies"
Tuesday, June 24, 2008

Seattle Times
"An eye toward affordability"
Saturday, July 8, 2006

Puget Sound Business Journal
"Alder nails $16M fund"
Friday, July 7, 2006

BioWorld Today
"Yeast-Based Antibodies Help Alder Raise $11M in Series A Financing"
Tuesday, August 16, 2005

Seattle Times
"Groundbreaking research by Alder starts to pay off"
Friday, August 12, 2005

Seattle Post Intelligencer
"New drug technology pays off"
Friday, August 12, 2005